Literature DB >> 15071491

Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis.

E Aganna1, P N Hawkins, S Ozen, T Pettersson, A Bybee, S A McKee, H J Lachmann, L Karenko, A Ranki, A Bakkaloglu, N Besbas, R Topaloglu, H M Hoffman, G A Hitman, P Woo, M F McDermott.   

Abstract

We investigated the hypothesis that low-penetrance mutations in genes (TNFRSF1A, MEFV and NALP3/CIAS1) associated with hereditary periodic fever syndromes (HPFs) might be risk factors for AA amyloidosis among patients with chronic inflammatory disorders, including rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), Crohn's disease, undiagnosed recurrent fevers and HPFs themselves. Four of 67 patients with RA plus amyloidosis had MEFV variants compared with none of 34 RA patients without amyloid (P value=0.03). The E148Q variant of MEFV was present in two of the three patients with TNF receptor-associated periodic syndrome (TRAPS) complicated by amyloid in two separate multiplex TRAPS families containing 5 and 16 affected members respectively, and the single patient with Muckle-Wells syndrome who had amyloidosis was homozygous for this variant. The R92Q variant of TNFRSF1A was present in two of 61 JIA patients with amyloidosis, and none of 31 nonamyloidotic JIA patients. No HPF gene mutations were found in 130 healthy control subjects. Although allelic variants in HPFs genes are not major susceptibility factors for AA amyloidosis in chronic inflammatory disease, low-penetrance variants of MEFV and TNFRSF1A may have clinically significant proinflammatory effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071491     DOI: 10.1038/sj.gene.6364070

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  20 in total

1.  Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever.

Authors:  D O Tchernitchko; M Gérard-Blanluet; M Legendre; C Cazeneuve; G Grateau; S Amselem
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

2.  Rutin modulates ASC expression in NLRP3 inflammasome: a study in alcohol and cerulein-induced rat model of pancreatitis.

Authors:  Ravikumar Aruna; Arumugam Geetha; Periyanayagam Suguna
Journal:  Mol Cell Biochem       Date:  2014-07-25       Impact factor: 3.396

Review 3.  Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).

Authors:  Francesco La Torre; Maurizio Muratore; Antonio Vitale; Fulvio Moramarco; Laura Quarta; Luca Cantarini
Journal:  Rheumatol Int       Date:  2015-06-06       Impact factor: 2.631

4.  Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.

Authors:  N Ravet; S Rouaghe; C Dodé; J Bienvenu; J Stirnemann; P Lévy; M Delpech; G Grateau
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

5.  Inflammasome is a central player in the induction of obesity and insulin resistance.

Authors:  Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

6.  E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever.

Authors:  R Topaloglu; F Ozaltin; E Yilmaz; S Ozen; B Balci; N Besbas; A Bakkaloglu
Journal:  Ann Rheum Dis       Date:  2004-09-30       Impact factor: 19.103

7.  Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.

Authors:  Rezan Topaloglu; Ezgi Deniz Batu; Diclehan Orhan; Seza Ozen; Nesrin Besbas
Journal:  Pediatr Nephrol       Date:  2015-11-12       Impact factor: 3.714

8.  Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene.

Authors:  Luca Cantarini; Orso Maria Lucherini; Gabriele Simonini; Mauro Galeazzi; Cosima Tatiana Baldari; Rolando Cimaz
Journal:  Rheumatol Int       Date:  2010-01-01       Impact factor: 2.631

9.  Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network.

Authors:  Antonio Vitale; Laura Obici; Marco Cattalini; Giuseppe Lopalco; Giampaolo Merlini; Nicola Ricco; Alessandra Soriano; Francesco La Torre; Elena Verrecchia; Antonella Insalaco; Lorenzo Dagna; Masen Abdel Jaber; Davide Montin; Giacomo Emmi; Luisa Ciarcia; Sara Barneschi; Paola Parronchi; Piero Ruscitti; Maria Cristina Maggio; Ombretta Viapiana; Jurgen Sota; Carla Gaggiano; Roberto Giacomelli; Ludovico Luca Sicignano; Raffaele Manna; Alessandra Renieri; Caterina Lo Rizzo; Bruno Frediani; Donato Rigante; Luca Cantarini
Journal:  Front Med (Lausanne)       Date:  2021-07-08

10.  Developments in the scientific and clinical understanding of autoinflammatory disorders.

Authors:  Helen J Lachmann; Philip N Hawkins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.